Cabaletta Bio Inc
CABA
Get informed when a big investor buys or sells
+ FollowMarket Cap$616.35M
Close$
$0.55
84.7% downside
Current Fair Value
84.7% downsideOvervalued by 84.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $616.35 Million |
|---|---|
| Enterprise Value | $526.16 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.64 |
| Beta | 3.17 |
| Outstanding Shares | 112,025,474 |
Return
| Return on Equity | -169.82% |
|---|---|
| Return on Assets | -118.42% |
| Return on Invested Capital | -169.63% |
Valuation & Multiples
| P/E Ratio | -2.41 |
|---|---|
| PEG | -11.46 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -2.91 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.26 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 21, 2026
EPS Estimate
$-0.41
Average shareholder expectationRevenue Estimate
$1.67 M
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-0.37
Average shareholder expectationRevenue Estimate
$1.67 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0659▲ 0.11% |
|---|---|
| Total Calls | 2,226,800▲ 67.27% |
| Total Puts | 146,700▲ 69.99% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 82.80%▲ 8.24% |
|---|---|
| Total Invested | $227.51M▲ 36.29% |
| Investors Holding | 118▲ 20.00% |
ESG Score
No data